Since promoter CpG methylation is known to affect the function of a gene by influencing the expression, we conducted an analysis of correlations between the transcript levels of FABP3 and several key MetS phenotypes pertinent to lipid metabolism. The gene discussed is FABP3; the disease is metabolic syndrome.